GALAXYSURF Galaxy Surfactants Q4 FY26 results (Jan–Mar 2026) and concall
Galaxy Surfactants reported a challenging Q4 FY26 marked by geopolitical disruptions and raw material price escalations, leading to a decline in EBITDA and volumes in AMET and RoW regions. However, India showed resilience with 8% volume growth, and the Americas emerged as a bright spot. Management provided optimistic guidance for Q1 FY27, expecting recovery and continued growth in specialty segments.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 14.8%, net profit down 18.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,063 | 1,042 | 1,145 | 1,278 | 1,326 +25% | 1,329 +28% | 1,315 +15% |
| EBITDA | 128 | 106 | 127 | 124 | 110 −14% | 119 +12% | 122 −4% |
| Net profit | 85 | 65 | 76 | 79 | 66 −22% | 59 −9% | 62 −18% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





